Clinical Trials Logo

Clinical Trial Summary

To determine the effects of policosanol on the cholesterol profile.


Clinical Trial Description

The primary objectives of this study are to determine the changes in the lipid profile [LDL-C, HDL-C, triglycerides, total cholesterol] and the emerging risk factor, Lp(a), when policosanol is added to statin therapy. Additionally, one more primary objective is to evaluate the safety of the combination regimen. ;


Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT00510809
Study type Interventional
Source University of Kansas Medical Center
Contact
Status Completed
Phase N/A
Start date July 2007
Completion date May 2010

See also
  Status Clinical Trial Phase
Terminated NCT00965055 - Ezetimibe in Patients Hypo-responsive to Statins Phase 3
Completed NCT03542240 - Effects of Curcumin Supplementation on Gut Barrier Function in Patients With Metabolic Syndrome N/A
Recruiting NCT06192251 - Complete Lifestyle Medicine Intervention Program
Completed NCT01004237 - Additive Effects of Pravastatin and Valsartan Phase 4
Completed NCT01187056 - The RISAP-study: a Complex Intervention in Risk Communication and Shared Decision-making in General Practice N/A
Completed NCT06227819 - BVA-200 vs BVA-100 Validation Study
Completed NCT05266586 - Study to Evaluate the Effect of Obicetrapib in Combination With Ezetimibe as an Adjunct to HIS Therapy Phase 2
Completed NCT03084822 - Cardiovascular Health Promotion Among African-Americans by FAITH! N/A
Completed NCT04317690 - Online Trial Examining Validity and Reliability of the Shared Decision Making Process Survey
Completed NCT04317274 - Online Trial Examining Validity of the Shared Decision Making Process Survey With Video Vignettes N/A
Recruiting NCT06005597 - Study of Obicetrapib & Ezetimibe Fixed Dose Combination on Top of Maximum Tolerated Lipid-Modifying Therapies Phase 3
Withdrawn NCT04510844 - Evolocumab In Advanced Chronic Kidney Disease Trial Phase 4
Completed NCT05421078 - A Dose-Finding Study in Japanese Patients to Evaluate the Effect of Obicetrapib as an Adjunct to Stable Statin Therapy. Phase 2
Completed NCT03528031 - Habitual Diet and Avocado Trial N/A
Completed NCT04964544 - Technology-Assisted Cholesterol Trial in Consumers (TACTiC) Phase 3
Active, not recruiting NCT05425745 - Evaluate the Effect of Obicetrapib in Patients With HeFH on Top of Maximum Tolerated Lipid-Modifying Therapies. Phase 3
Completed NCT00833976 - Omega-3 Fatty Acids (Lovaza) for Second Generation Antipsychotic-Associated Hypertriglyceridemia Phase 4
Terminated NCT04154579 - Arts & Health Education to Improve Health, Resilience, and Well-Being N/A
Recruiting NCT06350604 - Project WHADE: A Partner-Based Physical Activity Program for Women N/A
Not yet recruiting NCT05473325 - Benchtop NMR Spectroscopy for Assessment of Clinical Human Pathologies (BRANCH-P STUDY)